All News

This episode of the Cancer Horizons podcast features genitourinary oncologist Ulka Vaishampayan, MBBS, and is sponsored by Bristol Myers Squibb.

Researchers have found that, among patients with relapsed/refractory multiple myeloma who received treatment with the CAR-T cell therapy Abecma, race and ethnicity played roles in safety and response but not survival.

Recent years have brought more targeted agents to the frontline treatment for patients with chronic lymphocytic leukemia.

Managing side effects from lung cancer treatment with dose reductions is an approach experts have been using more, even though some patients voice concerns about lowering a drug’s impact on the disease.

Can I be honest with you?

Checking PSA levels following treatment is crucial among patients with nonmetastatic, unfavorable risk prostate cancer, according to the co-author of a recent study.

CURE® editors take a look back on last week’s major oncology headlines, from the cancer drug shortage to FDA approvals and the potential benefit of sexual activity for cervical cancer survivors.

Patients with extensive-stage small cell lung cancer responded well to the treatment of Trodelvy, according to preliminary results from a phase 2 trial.

My world turned upside down in April 2013 on the anniversary of my mother in laws death from metastatic breast cancer.

It is happening again.

When I was diagnosed with a rare cancer at the “stump” of my appendix, I was surprised, considering I had my appendix removed more than a decade ago.

Stephen Peck created a nonprofit that addressed the unique needs of men caring for someone with cancer.

Choosing to share your cancer story is a very personal choice.

From Suzanne Somers’ death from metastatic breast cancer and Julia Louis-Dreyfus discusses her outlook on life post-diagnosis, here is what’s happening in the oncology space this week.

In this on-demand webinar series, CURE partnered with Look Good Feel Better to offer fun wig options for patients to wear after hair loss from cancer treatment.

In this on-demand webinar series, CURE partnered with Look Good Feel Better to discuss how patients with cancer can care for their wig.

In this on-demand webinar series, CURE partnered with Look Good Feel Better to show how patients who experienced hair loss from cancer treatment can style their wigs.

In this on-demand webinar series, CURE partnered with Look Good Feel Better to demonstrate how to put on and adjust a wig for comfort and appearance for patients with cancer who have experienced hair loss from treatment.

In this on-demand webinar series, CURE partnered with Look Good Feel Better to offer patients with cancer offered tips for haircare and hair loss before, during and after treatment.

Two phase 3 randomized trials focused on evaluating the safety and efficiency of anamorelin to treat adult patients with advanced non-small cell lung cancer linked with weight loss and cachexia.

Patients insured by Medicaid may be more likely to be affected by the ongoing cancer drug shortage, according to a recent survey.

Dear every oncology team...

Charlene Wexler, the Chicago-based author of the Laughter and Tears series of novels, is an ovarian cancer survivor who now has skin cancer. She told CURE® about how her son’s death from leukemia led to her re-invention as a writer.

I was diagnosed with a rare cancer in 2007, and it shaped who I am today.

Recent research has put a spotlight on a number of factors which could be used to estimate which patients with nonmetastatic, unfavorable-risk prostate cancer are at high risk for a shorter time until PSA recurrence and failure.

A first patient received samuraciclib plus Orserdu in a phase 2 trial, a treatment combination for some patients with HR-positive, HER2-negative metastatic breast cancer.

One expert explained how care team aspects such as open dialogue, support and validation can help to inform patients with MPN about psychosocial needs that tend to be unmet.

Sometimes, it is better to keep things to yourself when it comes to cancer.

The Food and Drug Administration approved Keytruda plus chemotherapy for patients with locally advanced unresectable or metastatic biliary tract cancer.